Morgantown, W.Va.-based WVU Medicine Cancer Institute and Ann Arbor-based Michigan Medicine are participating in the world’s first in-human phase 1 clinical trial of an electric implant for the treatment of pancreatic cancer.
The small, implantable device delivers chemotherapy directly into pancreatic tissue through low-voltage electric pulses, according to a May 20 news release from WVU Medicine.
The trial is enrolling patients with nonmetastatic, locally advanced, unresectable pancreatic cancer, the release said.
